Intuitive Surgical, Inc. $ISRG Shares Bought by Rossby Financial LCC

Rossby Financial LCC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 55.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 304 shares of the medical equipment provider’s stock after purchasing an additional 108 shares during the period. Rossby Financial LCC’s holdings in Intuitive Surgical were worth $165,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after acquiring an additional 453,335 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after acquiring an additional 71,794 shares during the last quarter. Northern Trust Corp grew its holdings in shares of Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after acquiring an additional 11,988 shares during the last quarter. Wellington Management Group LLP increased its stake in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Finally, Nuveen LLC acquired a new stake in Intuitive Surgical during the 1st quarter worth about $1,715,899,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $545.39 on Wednesday. The company has a market capitalization of $195.51 billion, a price-to-earnings ratio of 72.14, a P/E/G ratio of 5.07 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The business’s 50-day moving average is $460.82 and its 200-day moving average is $497.70.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the firm posted $1.84 earnings per share. The firm’s revenue was up 22.9% on a year-over-year basis. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director directly owned 1,074 shares in the company, valued at $504,898.14. The trade was a 23.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Craig H. Barratt sold 2,193 shares of the business’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $548.01, for a total value of $1,201,785.93. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 88,324 shares of company stock valued at $46,093,939. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on ISRG shares. Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Leerink Partners lifted their target price on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Finally, Robert W. Baird set a $655.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.